ATLANTA -- For people with stable coronary artery disease and refractory angina, a coronary sinus reducer (CSR) implant showed a symptom alleviation benefit in the small placebo-controlled ...

A recent state-of-the-art review overlooks a “safe and effective” therapy for patients with stable angina and no good treatment options, according to several cardiologists. The coronary sinus reducer ...

A device that narrows the coronary sinus can reduce angina symptoms and improve quality of life in patients with refractory angina who are not candidates for revascularization, according to phase II ...

ATLANTA, GA — Despite failing to increase perfusion as hypothesized, a coronary sinus reducer (CSR) in a sham-controlled randomized trial meaningfully reduced angina and improved quality of life in ...

The coronary sinus is a collection of smaller veins that merge together to form the sinus (or large vessel), which is located along the heart’s posterior (rear) surface between the left ventricle and ...

People with chronic chest pain who received a coronary sinus reducer (CSR)—a stent thought to increase the amount of oxygen-rich blood flowing to the heart muscle—experienced significant reductions in ...

Please provide your email address to receive an email when new articles are posted on . A coronary sinus reducer reduced the frequency of angina events for patients with significant CAD. However, the ...

The coronary sinus reducer (CSR), an hourglass-shaped stent that narrows the coronary sinus to increase coronary sinus pressure, has shown some promise in treating patients with refractory angina. But ...

To the Editor: Verheye et al. (Feb. 5 issue) 1 report the results of the Coronary Sinus Reducer for Treatment of Refractory Angina (COSIRA) trial. Patients were excluded if they had abnormal ...

Angina is pain or constricting discomfort that typically occurs in the front of the chest (but may radiate to the neck, shoulders, jaw or arms). It is brought on by physical exertion or emotional ...

We thank Professor Mohl and colleagues for raising the concept of 'embryonic recall' as an alternative link between coronary sinus activation and cardiac regeneration. 1 This well-written viewpoint ...

Paz and colleagues' findings, however, indicate improvements in myocardial ischemia after permanently reducing coronary venous outflow with a CSRS introduced into the silent zone of the great cardiac ...